Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone
β Scribed by Phoebe Holmes; Joshua Lloyd; Inna Chervoneva; Edward Pequinot; Dennis B. Cornfield; Gordon F. Schwartz; Kathleen G. Allen; Juan P. Palazzo
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 295 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Although in recent years there has been a dramatic increase in both the incidence of ductal carcinoma in situ (DCIS) and breast-conserving therapy for patients who have this disease, the optimal treatment for these patients remains controversial. Most data regarding outcomes have co
## Abstract ## BACKGROUND A number of conventional histopathologic features have been associated with recurrence of ductal carcinoma in situ (DCIS) after surgery alone and are included in the Van Nuys Pathologic Classification and Prognostic Index. To the authors' knowledge, very little is known r
## Abstract ## Background and Objectives Elevated expression of cyclooxygenaseβ2 (COXβ2) has been established to be a feature of breast cancer. There has been inconsistency in the literature regarding the precise significance of thisβsome studies have found no clinicopathological relevance at all,
## Abstract ## BACKGROUND Ductal carcinoma in situ (DCIS) represents 20% of newly diagnosed breast carcinoma cases. Historically, the incidence of axillary metastasis in DCIS has been small (1β2%) and its significance has been debated. It is widely known that serial sections of lymph nodes coupled